Generic Avapro
Avapro is used to treat hypertension and kidney problems (diabetic nephropathy) caused by diabetes.
- Category: Blood Pressure
- Active ingredient: Irbesartan
- Available Dosage: 150mg, 300mg
- Payment options: VISA, Mastercard, Amex, JCB, Dinners
- Delivery time: Airmail (10 - 21 days), EMS Trackable (5-9 days)
Buy Generic Avapro Online
Package | Price | |
---|---|---|
150mg x 180 pills Free Airmail shipping | CA $277.97 | |
150mg x 120 pills | CA $194.06 | |
150mg x 90 pills | CA $149.47 | |
150mg x 60 pills | CA $104.02 |
Package | Price | |
---|---|---|
300mg x 180 pills Free Airmail shipping | CA $472.03 | |
300mg x 120 pills Free Airmail shipping | CA $316.43 | |
300mg x 90 pills | CA $239.94 | |
300mg x 60 pills | CA $160.84 | |
300mg x 30 pills | CA $95.83 |
Medical Conditions
Diabetic Neuropathy, Hypertension
Generic Avapro information
Introduction
Avapro, whose active ingredient is irbesartan, belongs to the class of angiotensin II receptor blockers (ARBs) and is used primarily to treat high blood pressure (hypertension). It is marketed in the United Kingdom by Sanofi and is also prescribed for the management of diabetic kidney disease when proteinuria is present. Controlling blood pressure reduces the risk of cardiovascular events such as heart attack, stroke, and heart failure, which constitute a major public‑health burden in the UK.
What is Avapro?
Avapro is a tablet formulation that contains the selective angiotensin II receptor antagonist irbesartan. The drug was developed by Sanofi‑Genzyme and received marketing authorisation in the European Union in 2002. Irbesartan is the pharmacologically active compound; Avapro is the trade name that identifies the specific formulation, dosage strengths, and licensing information supplied by the manufacturer. In addition to the Avapro brand, irbesartan is available from other manufacturers under the same generic name, an attribute that is commonly referenced in UK prescribing practice.
How Avapro Works
Irbesartan blocks the binding of angiotensin II to the type 1 angiotensin II receptor (AT₁) located on vascular smooth‑muscle cells, adrenal tissue, and the renal proximal tubule. By preventing this interaction, the drug:
- Reduces vasoconstriction – leading to lower peripheral resistance.
- Diminishes aldosterone secretion – decreasing sodium and water re‑absorption.
- Mitigates sympathetic activation – which further lowers blood‑pressure spikes.
The antihypertensive effect typically appears within 1–2 hours after oral ingestion and reaches a stable plateau after 3–4 days of consistent dosing. Irbesartan is eliminated mainly through renal excretion (≈ 60 % unchanged) and hepatic metabolism (via CYP2C9), producing a half‑life of ~ 12 hours, which supports once‑daily dosing.
Conditions Treated with Avapro
Approved indication | Clinical relevance in the UK |
---|---|
Essential (primary) hypertension | Hypertension affects roughly 1 in 4 adults in England; sustained control reduces stroke and myocardial‑infarction incidence. |
Diabetic nephropathy with proteinuria (type 2 diabetes) | About 4 million people in the UK have diabetes; early ARB therapy slows progression to end‑stage renal disease. |
The drug’s capacity to lower both systemic and intraglomerular pressure makes it effective for the above conditions, and extensive trial data confirm a reduction in cardiovascular morbidity and mortality when used as part of a comprehensive treatment plan.
Suitable Candidates for Avapro Treatment
- Adults ≥ 18 years with confirmed stage 1–3 hypertension who require additional blood‑pressure reduction beyond ACE‑inhibitors or thiazide diuretics.
- Patients with type 2 diabetes and persistent albuminuria (≥ 30 mg/day), where renal protection is a therapeutic goal.
- Individuals who cannot tolerate ACE‑inhibitors because of cough or angioedema, as ARBs like irbersartan have a lower incidence of these adverse reactions.
Contra‑indications include: hypersensitivity to irbesartan, severe hepatic impairment, and co‑administration with dual‑renin‑angiotensin system blockade (e.g., simultaneous use of ACE‑inhibitors, direct renin inhibitors, or other ARBs). Caution is advised in patients with moderate to severe kidney disease or high serum potassium, where laboratory monitoring is essential.
Risks, Side Effects, and Interactions
Common adverse events
- Dizziness or light‑headedness – usually related to the initial fall in blood pressure.
- Upper respiratory tract infection – mild, self‑limiting.
- Hyperkalemia (↑ potassium) – more likely in patients with reduced renal function or those taking potassium‑sparring diuretics.
Rare adverse events
- Peripheral oedema – may reflect fluid shift in susceptible individuals.
- Myalgia or arthralgia – generally resolves without intervention.
Serious adverse events
- Severe hypotension – can lead to syncope, especially when combined with excessive alcohol or other vasodilators.
- Renal impairment – abrupt decline in glomerular filtration rate, particularly in patients with volume depletion or concurrent NSAIDs.
- Allergic reactions – angio‑edema, urticaria, or anaphylactoid responses require immediate medical attention.
Clinically relevant drug–drug interactions
- Potassium‑sparring diuretics (e.g., spironolactone, amiloride) – increase the risk of hyper‑kalaemia.
- Non‑steroidal anti‑inflammatory drugs (NSAIDs) – may blunt nephroprotective effect and precipitate renal dysfunction.
- Lithium – co‑administration can raise lithium levels, risking toxicity.
- CYP2C9 inhibitors (e.g., fluconazole, amiodarone) – may increase irbesartan plasma concentrations; dose adjustment might be required.
Practical Use: Dosing, Missed Dose, Overdose
Usual adult dosing (tablet strength 150 mg, 300 mg, or 600 mg):
- Hypertension – start with 150 mg once daily; increase to 300 mg after 2 weeks if target not achieved.
- Diabetic kidney disease – 300 mg once daily is standard, with titration up to 600 mg based on tolerance and renal function.
Missed dose – take the forgotten tablet as soon as remembered unless the next scheduled dose is within 2 hours; in that case, skip the missed dose and continue the regular regimen. Do not double the dose.
Overdose – symptoms may include marked hypotension, confusion, and renal failure. Immediate medical assistance is essential. Activated charcoal can be considered if presentation is early, and symptomatic care (intravenous fluids, vasopressors) is directed by a clinician.
Precautions
- Food – Avapro may be taken with or without food; a consistent routine improves absorption consistency.
- Alcohol – excessive intake can amplify hypotensive effects; moderation is advised.
- Comorbidities – patients with hepatic insufficiency, severe renal disease (eGFR < 30 mL/min/1.73 m²), or high serum potassium should undergo closer monitoring.
Buying Avapro from Our Online Pharmacy
Avapro can be obtained safely through our online pharmacy in the UK. Our service provides:
- Affordable pricing – close to manufacturer‑cost, making the medication accessible for patients on a limited budget.
- Verified quality – all tablets are sourced from licensed, GMP‑certified suppliers and undergo rigorous authenticity checks.
- Guaranteed delivery – discreet, reliable shipping (express delivery within 7 working days; standard airmail typically 2–3 weeks).
- International sourcing – as a pharmacy‑broker, we work with overseas licensed pharmacies, enabling a discreet service that respects patient privacy while complying with UK import regulations.
This model offers a cost‑effective alternative for individuals with restricted access to traditional pharmacies or where prescription‑coverage options are unavailable.
FAQ
-
**Is Avapro available in both brand‑name and generic forms in the UK?
Yes. Avapro is the brand‑name product produced by Sanofi, while generic irbesartan tablets contain the same active ingredient and are authorised by the MHRA for sale throughout the UK. -
**What appearance does an Avapro tablet have?
The 150 mg tablet is round, white to off‑white, film‑coated; the 300 mg tablet is also round but typically brownish‑beige. Imprint details (e.g., “150 AV”) differ between manufacturers. -
**Does Avapro need to be stored in a refrigerator?
No. Avapro should be stored at room temperature (15 – 25 °C), protected from moisture, heat, and direct sunlight. Refrigeration may affect tablet integrity. -
**Can I travel internationally with Avapo while on holiday?
Yes, provided you keep the medication in its original packaging, carry a copy of the prescription, and store it in a temperature‑controlled environment (e.g., a travel‑case rather than a car‑boot). Avoid exposing it to extreme heat or humidity. -
**Are there any known concerns for Asian patients taking Avapro?
Clinical data do not indicate ethnicity‑specific safety signals, but Asian individuals often have lower average body mass and may develop higher plasma concentrations; dose adjustment may be considered under clinical supervision. -
**What are the UK regulations for personal import of Avapro?
Individuals may import a three‑month supply for personal use with a valid prescription. Importation without a prescription can be refused by customs authorities, and the medication may be destroyed if it does not meet UK licensing standards. -
**Does Avapro contain any known allergens such as lactose or gluten?
The standard formulation of Avapro does not contain lactose or gluten. However, excipients may vary between manufacturers, so patients with severe sensitivities should review the specific product’s leaflet. -
**How does the half‑life of irbesartan compare with other ARBs?
Irbesartan’s half‑life (~ 12 hours) is comparable to losartan (6–9 hours) and longer than valsartan (5–9 hours). This pharmacokinetic profile supports once‑daily dosing without the need for split doses. -
**Is there any difference in tablet dissolution between UK‑produced and overseas‑produced Avapro?
All licensed tablets must meet the European Pharmacopeia dissolution standards. While minor formulation variations exist, bioequivalence is required for market authorisation, ensuring consistent absorption across regions. -
**Can Avapro be detected in standard drug‑screening tests for employment?
ARBs like irbesartan are not typically targeted by routine workplace drug‑screening panels, which focus on substances of abuse. Presence is unlikely to affect employment drug‑test results.
Glossary
- Angiotensin II receptor blocker (ARB)
- A class of drugs that inhibit the action of angiotensin II at the AT₁ receptor, resulting in vasodilation and reduced blood‑pressure levels.
- Hyperkalaemia
- An abnormally high concentration of potassium in the blood (generally > 5.5 mmol/L), which can impair cardiac conduction and cause arrhythmias.
- Bioequivalence
- A demonstration that two products (e.g., generic and brand) release the same amount of active ingredient into the bloodstream at comparable rates, ensuring similar therapeutic outcomes.
- Renin‑angiotensin system (RAS)
- A hormonal cascade that regulates blood‑pressure, fluid, and electrolyte balance; over‑activation contributes to hypertension and cardiovascular disease.
Disclaimer
The information provided about Avapro is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Avapro for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.
Alternative names or trademarks of Generic Avapro
Avapro may be marketed under different names in various countries.
All of them contain Irbesartan as main ingredient.
Some of them are the following:
Aprovel, Irbesartan, Adana, Karvea, Irovel, Xarb